Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


ALKERMES reported $289.64M in Loan Capital for its fiscal quarter ending in March of 2023.

Loan Capital Change
Amgen AMGN:US USD 60.76B 23.41B
Biogen BIIB:US USD 6.28B 1.7M
BioMarin Pharmaceutical BMRN:US USD 1.08B 803K
Eli Lilly LLY:US USD 18.88B 4.14B
Horizon Pharma HZNP:US USD 2.54B 2.61M
Ionis Pharmaceuticals IONS:US USD 1.18B 1.66M
J&J JNJ:US USD 34.93B 8.04B
Marinus Pharmaceuticals MRNS:US USD 71.5M 480K
Otsuka Holdings 4578:JP JPY 127.32B 22.69B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Revance Therapeutics RVNC:US USD 379.86M 485K
Vertex Pharmaceuticals VRTX:US USD 417.6M 13.2M